Valuation: Net Medical Xpress Solutions, Inc.

Market Cap 1.07M 933K 869K 798K 1.51M 102M 1.53M 10.24M 4.02M 51.02M 4.03M 3.94M 171M P/E 2015
32.9x
P/E 2016 -5.75x
Enterprise Value 827K 719K 669K 614K 1.16M 78.91M 1.18M 7.88M 3.09M 39.29M 3.1M 3.04M 132M EV / Sales 2015
1.04x
EV / Sales 2016 0.65x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
1 week-85.71%
Current month-85.71%
1 month-85.71%
3 months-85.71%
6 months-66.67%
Current year-66.67%
1 month 0
Extreme 0.0001
0
Current year 0
Extreme 0.0001
0
1 year 0
Extreme 0
0
3 years 0
Extreme 0
0.03
5 years 0
Extreme 0
0.75
10 years 0
Extreme 0
0.75
Manager TitleAgeSince
President - 26/06/2019
Director TitleAgeSince
Director/Board Member 64 01/01/2003
Director/Board Member 84 01/01/2005
Director/Board Member - 01/03/2018
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-85.71%-.--%-99.60% 26.4K
+2.50%+21.34%-13.19%+37.88% 3,350B
+0.33%+0.04%-22.35%+519.78% 293B
+1.33%+10.37%+94.64%+133.43% 95.6B
+1.72%+3.86%-7.06%+44.80% 91.66B
+4.41%+4.01%-38.68%-14.02% 71.29B
+0.78%+7.01%-31.69%+60.88% 65.07B
-1.91%+4.91%+9.11%+58.90% 46.26B
-27.34%-26.55%-74.65%-11.02% 34.85B
-0.79%+0.86%-30.60%-48.44% 30.8B
Average -1.92%+3.25%-11.45%+68.26% 407.83B
Weighted average by Cap. +1.96%+0.36%-12.32%+73.53%

Financials

2015 2016
Net sales 4.22M 3.67M 3.42M 3.14M 5.92M 403M 6.01M 40.27M 15.8M 201M 15.86M 15.51M 673M 3.04M 2.65M 2.46M 2.26M 4.27M 291M 4.34M 29.04M 11.4M 145M 11.44M 11.18M 485M
Net income 151K 131K 122K 112K 212K 14.41M 215K 1.44M 565K 7.18M 567K 555K 24.06M -344K -299K -278K -256K -483K -32.84M -490K -3.28M -1.29M -16.35M -1.29M -1.26M -54.82M
Net Debt -340K -296K -275K -253K -477K -32.46M -484K -3.24M -1.27M -16.16M -1.28M -1.25M -54.18M -247K -215K -200K -183K -347K -23.58M -352K -2.36M -925K -11.74M -928K -907K -39.36M
Logo Net Medical Xpress Solutions, Inc.
Net Medical Xpress Solutions, Inc. focuses on the development of artificial intelligence software named PrivateAI (Private Eye), developing clinical trials, and expanding immune defense products to different markets. The Company is also focusing on productizing hand-labeled image data for use in artificial intelligence training, verification, and validation of custom models. It focuses on artificial intelligence for medical research, clinical trials, and Food and Drug Administration (FDA) compliance, which includes cybersecurity audit products designed to meet the FDA's new mandates for connected devices. Through its subsidiary, Immunity Science, Inc., the Company provides a variety of over-the-counter vitamins, supplements, air purifiers, nasal sprays, and drug-free pain patches. It offers its products through the Website www.immunityscience.store direct to consumers. In addition, products are available from distribution centers at retail locations.
Employees
23
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. NMXS Stock